Amendment of February 4, 2004, Order To Embargo Birds and Bird Products Imported From Albania, Azerbaijan, Cameroon, and Myanmar, 14532-14533 [06-2767]
Download as PDF
14532
Federal Register / Vol. 71, No. 55 / Wednesday, March 22, 2006 / Notices
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Evaluation of the Spanish-Language
Campaign Good Morning Arthritis,
Today You Will Not Defeat Us.—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Arthritis affects nearly 43 million
Americans, or about one in every six
people, and is the leading cause of
disability among adults in the United
States. Because of the broad public
health impact of this disease, the
Centers for Disease Control and
Prevention (CDC) developed the
National Arthritis Action Plan in 1998
as a comprehensive approach to
reducing the burden of arthritis in the
United States.
As part of its efforts to implement the
National Arthritis Action Plan, CDC
developed and tested a health
communications campaign promoting
physical activity among Caucasian and
African-American adults with arthritis.
In 2003–2004, CDC developed a similar
campaign for Spanish-speaking people
with arthritis. Hispanic populations
have a slightly lower prevalence rate of
self-reported, doctor-diagnosed arthritis,
but Hispanics with arthritis report
greater work limitations, and higher
rates of severe pain than do Caucasian
populations with arthritis.
The Spanish-language campaign,
Good Morning Arthritis, Today You Will
Not Defeat Us, is designed to reach
Spanish speaking adults with arthritis
who are aged 45–64, who have high
school education or less, and whose
annual income is less than $35,000. The
key message elements of the Spanish
language health communications
campaign are similar to its English
counterpart, as are the campaign
objectives and materials. The campaign
objectives are to increase target
audience members’ (1) Beliefs about
physical activity as an arthritis
management strategy (there are ‘‘things
they can do’’ to make arthritis better,
and physical activity is an important
part of arthritis management); (2)
Knowledge of the benefits of physical
activity and appropriate physical
activity for people with arthritis; (3)
Confidence in their ability to be
physically active, and (4) Trial of
physical activity behaviors. Based on
formative research, campaign materials
refer to exercise instead of physical
activity. Campaign materials include;
print ads, 30- and 60-second radio ads
and public service announcements, and
desktop displays with brochures for
pharmacies, doctors’ offices, and
community centers.
In the Fall of 2005, the Spanish
language campaign was pilot tested by
5 state health departments that receive
funding from CDC for their arthritis
programs. CDC will eventually
disseminate these materials to all 36
CDC-funded states. The 5 preliminary
pilot tests focused on reach and
exposure; a more thorough evaluation is
necessary to assess impact of the
campaign. This information will be used
to guide the public health practice of the
36 state arthritis programs and their
partners.
CDC will conduct an evaluation of the
impact of the Spanish language health
communications campaign on the
exercise/physical activity-related
attitudes, beliefs, and behaviors among
the target audience of Spanish-speaking
people with arthritis. There are no costs
to respondents other than their time.
ESTIMATED ANNUALIZED BURDEN
Number of
respondents
Respondents
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Screening Survey ............................................................................................
Telephone Survey ............................................................................................
12,000
2,500
1
1
2/60
15/60
400
625
Total ..........................................................................................................
........................
........................
........................
1,025
Dated: March 16, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–4119 Filed 3–21–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
cprice-sewell on PROD1PC70 with NOTICES
Centers for Disease Control and
Prevention
Amendment of February 4, 2004, Order
To Embargo Birds and Bird Products
Imported From Albania, Azerbaijan,
Cameroon, and Myanmar
SUMMARY: On February 4, 2004, the
Centers for Disease Control and
Prevention (CDC) within the U.S.
VerDate Aug<31>2005
14:47 Mar 21, 2006
Jkt 208001
Department of Health and Human
Services issued an order to ban
immediately the import of all birds
(Class: Aves) from specified Southeast
Asian countries, subject to limited
exemptions for returning pet birds of
U.S. origin and certain processed birdderived products. HHS/CDC took this
step because birds from these countries
potentially can infect humans with
avian influenza (influenza A/ [H5N1]).
The February 4, 2004, order
complemented a similar action taken at
the same time by the Animal and Plant
Health Inspection Services (APHIS)
within the U.S. Department of
Agriculture (USDA).
On March 10, 2004, HHS/CDC lifted
the embargo of birds and bird products
from the Hong Kong Special
Administrative Region (HKSAR)
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
because of the documented publichealth and animal health measures
taken by Hong Kong officials to prevent
spread of the outbreak with the HKSAR,
and the absence of highly pathogenic
avian influenza H5N1 cases in Hong
Kong’s domestic and wild bird
populations. USDA/APHIS took a
similar action. On September 28, 2004,
HHS/CDC extended the embargo on
birds and bird products to include
Malaysia because of the documented
cases of highly pathogenic avian
influenza A H5N1 in poultry in
Malaysia. On July 20, 2005, USDA/
APHIS adopted as a final rule the
interim rule that became effective on
February 4, 2004, which amended its
regulations to prohibit or restrict the
importation of birds, poultry, and
unprocessed birds and poultry products
E:\FR\FM\22MRN1.SGM
22MRN1
Federal Register / Vol. 71, No. 55 / Wednesday, March 22, 2006 / Notices
cprice-sewell on PROD1PC70 with NOTICES
from regions that have reported the
presence of highly pathogenic avian
influenza H5N1 in poultry. (See 70
Federal Register 41608 [July 20, 2005].)
As the United Nations Food and
Agriculture Organization and the World
Organization for Animal Health (OIE)
have confirmed additional cases of
highly pathogenic avian influenza
(H5N1), USDA/APHIS has added
additional countries to its ban. On
December 29, 2005, HHS/CDC added
the Republic of Kazakhstan, Romania,
the Russian Federation, the Republic of
Turkey, and Ukraine to its current
embargo because of documented cases
of highly pathogenic avian influenza
H5N1 in poultry in those countries. On
February 8, 2006, HHS/CDC added
Nigeria to its embargo because of the
documentation of highly pathogenic
avian influenza H5N1 in poultry. On
February 22, 2006, HHS/CDC added
India to its embargo because of
documentation of highly pathogenic
avian influenza H5N1 in poultry. On
February 27, 2006, added Egypt to its
embargo because of documentation of
highly pathogenic avian influenza H5N1
in poultry. On March 2, 2006, CDC
issued an amendment adding Niger to
its embargo after H5N1 was confirmed
in poultry.
On February 24, 2006, OIE reported
confirmation of highly pathogenic avian
influenza H5N1 in poultry in
Azerbaijan. On March 7, 2006, OIE
reported confirmation of highly
pathogenic avian influenza H5N1 in
poultry in Albania. On March 11, 2006,
OIE reported confirmation of highly
pathogenic avian influenza H5N1 in
poultry in Cameroon. On March 12,
2006, OIE reported confirmation of
highly pathogenic avian influenza H5N1
in poultry in Myanmar. USDA/APHIS
subsequently added Albania,
Azerbaijan, Cameroon, and Myanmar to
their ban. At this time, HHS/CDC is
adding Albania, Azerbaijan, Cameroon,
and Myanmar to its current embargo.
This action is effective on March 15,
2006, and will remain in effect until
further notice.
SUPPLEMENTARY INFORMATION:
Background
On February 24, OIE reported
laboratory confirmation of highly
pathogenic avian influenza in poultry in
Azerbaijan.
On March 10, OIE reported laboratory
confirmation of highly pathogenic avian
influenza H5N1 in poultry in Albania in
the village of Cuke, Sarande County
(Viore State). The outbreak began on
February 16, 2006.
An outbreak of avian influenza due to
highly pathogenic virus H5N1 was
VerDate Aug<31>2005
14:47 Mar 21, 2006
Jkt 208001
repoted in duck farms in Doualare area
in Maroua, Cameroon. The outbreak
began on February 21, 2006, and
confirmation of infection was reported
by OIE on March 12, 2006.
An outbreak of highly pathogenic
avian influenza subtype H5N1 was
reported in poultry at Aung Myae Thar
Zan Township, in Mandalay Division,
Myanmar. The outbreak began on March
8, 2006, and confirmation of infection
was reported by OIE on March 12, 2006.
Introduction of birds infected with
highly pathogenic avian influenza H5N1
into the United States could lead to
outbreaks among birds and among the
human population, a significant public
health threat. Banning the importation
of all avian species from affected
countries is an effective menas of
limiting this threat. HHS/CDC is
therefore taking this action to reduce the
chance of introduction or spread of
influenza A H5N1 into the United
States.
14533
Food and Drug Administration
conference is intended to provide the
drug, device, and biologics industries
with an opportunity to interact with
FDA reviewers and compliance officers
from the centers and district offices, as
well as other industry experts. The main
focus of this interactive conference will
be product approval, compliance, and
risk management in the three medical
product areas. Industry speakers,
interactive question and answer, and
workshop sessions will also be included
to assure open exchange and dialogue
on the relevant regulatory issues.
Date and Time: The conference will
be held on May 23 and 24, 2006, from
7:30 a.m. to 5 p.m.
Location: The conference will be held
at the Fairmont Newport Beach Hotel,
4500 MacArthur Blvd., Newport Beach,
CA 92660.
Contact: Linda Hartley, Food and
Drug Administration, 19701 Fairchild,
Irvine, CA 92612, 949–608–4413, FAX:
949–608–4417, or OCRA, Attention to
Detail (ATD), 5319 University Dr., suite
641, Irvine, CA 92612, 949–387–9046,
FAX: 949–387–9047, Web site:
www.ocra-dg.org.
Registration and Meeting Information:
See OCRA Web site at www.ocra-dg.org.
Contact ATD at 949–387–9046.
Before April 24, 2006, registrations
fees are as follows: $525.00 for
members, $575.00 for nonmembers, and
$350.00 for FDA/government/full-time
students with the proper identification.
After April 24, 2006: $575.00 for
members, $625.00 for nonmembers, and
$350.00 for FDA/government/full-time
students with the proper identification.
The registration fee will cover actual
expenses including refreshments, lunch,
materials, parking, and speaker
expenses.
If you need special accommodations
due to a disability, please contact Linda
Hartley (see Contact) at least 10 days in
advance of the meeting.
The Ninth Annual Food and Drug
Administration–Orange County
Regulatory Affairs Educational
Conference
Dated: March 10, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–4092 Filed 3–21–06; 8:45 am]
Immediate Action
Therefore, pursuant to 41 CFR
71.32(b), HHS/CDC is amending the
February 4, 2004, order to add Albania,
Azerbaijan, Cameroon, and Myanmar to
the list of countries subject to the
order’s embargo of birds and productes
derived from birds. All other portions of
the February 4, 2004, order, as further
amended on March 10, 2004, September
28, 2004, December 29, 2005, February
8, 2006, February 22, 2006, February 27,
2006, and March 2, 2006 shall remain in
effect until further notice.
Dated: March 16, 2006.
Julie Louise Gerberding,
Director, Centers for Disease Control and
Prevention, U.S. Department of Health and
Human Services.
[FR Doc. 06–2767 Filed 3–21–06; 8:45 am]
BILLING CODE 4163–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
Food and Drug Administration,
BILLING CODE 4160–01–S
HHS.
ACTION:
Notice of meeting.
The Food and Drug Administration
(FDA) is announcing the following
conference: Ninth Annual Educational
Conference cosponsored with the
Orange County Regulatory Affairs
Discussion Group (OCRA). The
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\22MRN1.SGM
22MRN1
Agencies
[Federal Register Volume 71, Number 55 (Wednesday, March 22, 2006)]
[Notices]
[Pages 14532-14533]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-2767]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Amendment of February 4, 2004, Order To Embargo Birds and Bird
Products Imported From Albania, Azerbaijan, Cameroon, and Myanmar
SUMMARY: On February 4, 2004, the Centers for Disease Control and
Prevention (CDC) within the U.S. Department of Health and Human
Services issued an order to ban immediately the import of all birds
(Class: Aves) from specified Southeast Asian countries, subject to
limited exemptions for returning pet birds of U.S. origin and certain
processed bird-derived products. HHS/CDC took this step because birds
from these countries potentially can infect humans with avian influenza
(influenza A/ [H5N1]). The February 4, 2004, order complemented a
similar action taken at the same time by the Animal and Plant Health
Inspection Services (APHIS) within the U.S. Department of Agriculture
(USDA).
On March 10, 2004, HHS/CDC lifted the embargo of birds and bird
products from the Hong Kong Special Administrative Region (HKSAR)
because of the documented public-health and animal health measures
taken by Hong Kong officials to prevent spread of the outbreak with the
HKSAR, and the absence of highly pathogenic avian influenza H5N1 cases
in Hong Kong's domestic and wild bird populations. USDA/APHIS took a
similar action. On September 28, 2004, HHS/CDC extended the embargo on
birds and bird products to include Malaysia because of the documented
cases of highly pathogenic avian influenza A H5N1 in poultry in
Malaysia. On July 20, 2005, USDA/APHIS adopted as a final rule the
interim rule that became effective on February 4, 2004, which amended
its regulations to prohibit or restrict the importation of birds,
poultry, and unprocessed birds and poultry products
[[Page 14533]]
from regions that have reported the presence of highly pathogenic avian
influenza H5N1 in poultry. (See 70 Federal Register 41608 [July 20,
2005].) As the United Nations Food and Agriculture Organization and the
World Organization for Animal Health (OIE) have confirmed additional
cases of highly pathogenic avian influenza (H5N1), USDA/APHIS has added
additional countries to its ban. On December 29, 2005, HHS/CDC added
the Republic of Kazakhstan, Romania, the Russian Federation, the
Republic of Turkey, and Ukraine to its current embargo because of
documented cases of highly pathogenic avian influenza H5N1 in poultry
in those countries. On February 8, 2006, HHS/CDC added Nigeria to its
embargo because of the documentation of highly pathogenic avian
influenza H5N1 in poultry. On February 22, 2006, HHS/CDC added India to
its embargo because of documentation of highly pathogenic avian
influenza H5N1 in poultry. On February 27, 2006, added Egypt to its
embargo because of documentation of highly pathogenic avian influenza
H5N1 in poultry. On March 2, 2006, CDC issued an amendment adding Niger
to its embargo after H5N1 was confirmed in poultry.
On February 24, 2006, OIE reported confirmation of highly
pathogenic avian influenza H5N1 in poultry in Azerbaijan. On March 7,
2006, OIE reported confirmation of highly pathogenic avian influenza
H5N1 in poultry in Albania. On March 11, 2006, OIE reported
confirmation of highly pathogenic avian influenza H5N1 in poultry in
Cameroon. On March 12, 2006, OIE reported confirmation of highly
pathogenic avian influenza H5N1 in poultry in Myanmar. USDA/APHIS
subsequently added Albania, Azerbaijan, Cameroon, and Myanmar to their
ban. At this time, HHS/CDC is adding Albania, Azerbaijan, Cameroon, and
Myanmar to its current embargo. This action is effective on March 15,
2006, and will remain in effect until further notice.
SUPPLEMENTARY INFORMATION:
Background
On February 24, OIE reported laboratory confirmation of highly
pathogenic avian influenza in poultry in Azerbaijan.
On March 10, OIE reported laboratory confirmation of highly
pathogenic avian influenza H5N1 in poultry in Albania in the village of
Cuke, Sarande County (Viore State). The outbreak began on February 16,
2006.
An outbreak of avian influenza due to highly pathogenic virus H5N1
was repoted in duck farms in Doualare area in Maroua, Cameroon. The
outbreak began on February 21, 2006, and confirmation of infection was
reported by OIE on March 12, 2006.
An outbreak of highly pathogenic avian influenza subtype H5N1 was
reported in poultry at Aung Myae Thar Zan Township, in Mandalay
Division, Myanmar. The outbreak began on March 8, 2006, and
confirmation of infection was reported by OIE on March 12, 2006.
Introduction of birds infected with highly pathogenic avian
influenza H5N1 into the United States could lead to outbreaks among
birds and among the human population, a significant public health
threat. Banning the importation of all avian species from affected
countries is an effective menas of limiting this threat. HHS/CDC is
therefore taking this action to reduce the chance of introduction or
spread of influenza A H5N1 into the United States.
Immediate Action
Therefore, pursuant to 41 CFR 71.32(b), HHS/CDC is amending the
February 4, 2004, order to add Albania, Azerbaijan, Cameroon, and
Myanmar to the list of countries subject to the order's embargo of
birds and productes derived from birds. All other portions of the
February 4, 2004, order, as further amended on March 10, 2004,
September 28, 2004, December 29, 2005, February 8, 2006, February 22,
2006, February 27, 2006, and March 2, 2006 shall remain in effect until
further notice.
Dated: March 16, 2006.
Julie Louise Gerberding,
Director, Centers for Disease Control and Prevention, U.S. Department
of Health and Human Services.
[FR Doc. 06-2767 Filed 3-21-06; 8:45 am]
BILLING CODE 4163-18-M